|

Belvarafenib Clinical Trials

2 actively recruiting trials across 1 location

Also known as: HM95573

Pipeline

Phase 2: 2

Top Sponsors

  • Hoffmann-La Roche1
  • Hanmi Pharmaceutical Company Limited1

Indications

  • Cancer2
  • Advanced or Metastatic Melanoma1
  • Solid Tumors1

Other1 trial

Belvarafenib in Combination With Cobimetinib in Patients With Locally Advanced or Metastatic NRAS-Mutant Melanoma
Phase 2

Daphne, Alabama1 trial

Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Southern Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.